Skip to main content

Monday's ETF Winners & Losers

Funds tracking biotech and energy are rising.

Biotech-related exchange-traded funds were among the day's top performers, helped by an 18% jump in shares of




Earlier, the company said it will be acquired by


(AZN) - Get Astrazeneca PLC Sponsored ADR Report

in an arrangement worth more than $15 billion.


SPDR S&P Biotech


ETF was gaining $1.02, or 2%, to $52.96. The

HealthShares Emerging Cancer


was higher by 47 cents, or 1.8%, to $26.94. The

First Trust Amex Biotechnology Index

TheStreet Recommends

(FBT) - Get First Trust NYSE Arca Biotechnology Index Fund Report

tacked on 38 cents, or 1.5%, to $26.01. The

iShares Nasdaq Biotechnology

(IBB) - Get iShares Biotechnology ETF Report

ETF was recently up $1.01, or 1.2%, to $82.47.

Bundled securities tracking the energy sector were also among the winners of the day thanks to a gain in oil prices. The front-month June crude contract was recently adding $1.15 to $65.26 a barrel.


iPath Goldman Sachs Crude Oil Index

(OIL) - Get iPath Pure Beta Crude Oil ETN Report

was rising 75 cents, or 2.1%, to $37.30. The

United States Oil

(USO) - Get United States Oil Fund LP Report

ETF gained 92 cents, or 1.8%, to $50.97. The

PowerShares DB Energy

(DBE) - Get Invesco DB Energy Fund Report

ETF was climbing 44 cents, or 1.6%, to $27.87.

On the other hand, housing-related ETFs were the worst performers of the session. Among individual housing names,

D.R. Horton

(DHI) - Get D.R. Horton, Inc. Report

slid 3.7%,


(LEN) - Get Lennar Corporation Class A Report

was sinking 2.9%,

Toll Brothers

(TOL) - Get Toll Brothers, Inc. Report

slumped 2.2%, and


(HOV) - Get Hovnanian Enterprises, Inc. Class A Report

was down 1.8%.


iShares Dow Jones U.S. Home Construction

(ITB) - Get iShares U.S. Home Construction ETF Report

ETF was recently down 69 cents, or 1.9%, at $36.37. The

SPDR Homebuilders

(XHB) - Get SPDR S&P Homebuilders ETF Report

ETF was losing 60 cents, or 1.7%, to $34.49.